Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial
Proton-pump inhibitors (PPI) are liberally prescribed in patients with liver cirrhosis. Observational studies link PPI therapy in cirrhotic patients with an increased risk for infectious complications, hepatic encephalopathy and an increased risk for hospitalization and mortality. However, patients...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
12 April 2022
|
| In: |
Trials
Year: 2022, Jahrgang: 23, Pages: 1-13 |
| ISSN: | 1468-6694 |
| DOI: | 10.1186/s13063-022-06232-w |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13063-022-06232-w
|
| Verfasserangaben: | Malte H. Wehmeyer, Thomas Horvatits, Anika Buchholz, Linda Krause, Sarah Walter, Antonia Zapf, Ansgar W. Lohse, Johannes Kluwe and the STOPPIT-trial group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1801367728 | ||
| 003 | DE-627 | ||
| 005 | 20230427140312.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220511s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13063-022-06232-w |2 doi | |
| 035 | |a (DE-627)1801367728 | ||
| 035 | |a (DE-599)KXP1801367728 | ||
| 035 | |a (OCoLC)1341459811 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wehmeyer, Malte Hermann |e VerfasserIn |0 (DE-588)1062583388 |0 (DE-627)805482342 |0 (DE-576)419938532 |4 aut | |
| 245 | 1 | 0 | |a Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT) |b study protocol for a prospective, multicentre, controlled, randomized, double-blind trial |c Malte H. Wehmeyer, Thomas Horvatits, Anika Buchholz, Linda Krause, Sarah Walter, Antonia Zapf, Ansgar W. Lohse, Johannes Kluwe and the STOPPIT-trial group |
| 264 | 1 | |c 12 April 2022 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 11.05.2022 | ||
| 520 | |a Proton-pump inhibitors (PPI) are liberally prescribed in patients with liver cirrhosis. Observational studies link PPI therapy in cirrhotic patients with an increased risk for infectious complications, hepatic encephalopathy and an increased risk for hospitalization and mortality. However, patients with liver cirrhosis are also considered to be at risk for peptic ulcer bleeding. The STOPPIT trial evaluates if discontinuation of a pre-existing PPI treatment delays a composite endpoint of re-hospitalization and/or death in patients (recently) hospitalized with liver cirrhosis compared to patients on continued PPI medication. | ||
| 650 | 4 | |a Complications | |
| 650 | 4 | |a Esomeprazole | |
| 650 | 4 | |a Hepatic encephalopathy | |
| 650 | 4 | |a Hospitalization | |
| 650 | 4 | |a Infections | |
| 650 | 4 | |a Liver cirrhosis | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Pantoprazole | |
| 650 | 4 | |a PPI | |
| 650 | 4 | |a Side-effects | |
| 700 | 1 | |a Horvatits, Thomas |d 1985- |e VerfasserIn |0 (DE-588)1252980264 |0 (DE-627)1794838406 |4 aut | |
| 700 | 1 | |a Buchholz, Anika |d 1980- |e VerfasserIn |0 (DE-588)1129700097 |0 (DE-627)884343332 |0 (DE-576)486492052 |4 aut | |
| 700 | 1 | |a Krause, Linda |d 1991- |e VerfasserIn |0 (DE-588)1226459684 |0 (DE-627)1747618462 |4 aut | |
| 700 | 1 | |a Walter, Sarah |e VerfasserIn |0 (DE-588)125725376X |0 (DE-627)1801370109 |4 aut | |
| 700 | 1 | |a Zapf, Antonia |d 1981- |e VerfasserIn |0 (DE-588)140412611 |0 (DE-627)618380329 |0 (DE-576)317976486 |4 aut | |
| 700 | 1 | |a Lohse, Ansgar W. |d 1960- |e VerfasserIn |0 (DE-588)1027322840 |0 (DE-627)728895382 |0 (DE-576)372852483 |4 aut | |
| 700 | 1 | |a Kluwe, Johannes |d 1975- |e VerfasserIn |0 (DE-588)129908029 |0 (DE-627)483647519 |0 (DE-576)297897349 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trials |d London : BioMed Central, 2000 |g 23(2022), Artikel-ID 302, Seite 1-13 |h Online-Ressource |w (DE-627)326173552 |w (DE-600)2040523-6 |w (DE-576)107014556 |x 1468-6694 |7 nnas |a Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT) study protocol for a prospective, multicentre, controlled, randomized, double-blind trial |
| 773 | 1 | 8 | |g volume:23 |g year:2022 |g elocationid:302 |g pages:1-13 |g extent:13 |a Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT) study protocol for a prospective, multicentre, controlled, randomized, double-blind trial |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s13063-022-06232-w |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220511 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 125725376X |a Walter, Sarah |m 125725376X:Walter, Sarah |p 5 | ||
| 999 | |a KXP-PPN1801367728 |e 4131786117 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Malte H. Wehmeyer, Thomas Horvatits, Anika Buchholz, Linda Krause, Sarah Walter, Antonia Zapf, Ansgar W. Lohse, Johannes Kluwe and the STOPPIT-trial group"]},"language":["eng"],"note":["Gesehen am 11.05.2022"],"person":[{"family":"Wehmeyer","role":"aut","display":"Wehmeyer, Malte Hermann","given":"Malte Hermann"},{"family":"Horvatits","role":"aut","given":"Thomas","display":"Horvatits, Thomas"},{"given":"Anika","display":"Buchholz, Anika","role":"aut","family":"Buchholz"},{"given":"Linda","display":"Krause, Linda","role":"aut","family":"Krause"},{"role":"aut","family":"Walter","given":"Sarah","display":"Walter, Sarah"},{"display":"Zapf, Antonia","given":"Antonia","role":"aut","family":"Zapf"},{"role":"aut","family":"Lohse","display":"Lohse, Ansgar W.","given":"Ansgar W."},{"family":"Kluwe","role":"aut","display":"Kluwe, Johannes","given":"Johannes"}],"recId":"1801367728","id":{"doi":["10.1186/s13063-022-06232-w"],"eki":["1801367728"]},"physDesc":[{"extent":"13 S."}],"title":[{"subtitle":"study protocol for a prospective, multicentre, controlled, randomized, double-blind trial","title":"Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT)","title_sort":"Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT)"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"12 April 2022"}],"relHost":[{"recId":"326173552","id":{"zdb":["2040523-6"],"issn":["1468-6694","1745-6215"],"eki":["326173552"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Trials","title":"Trials"}],"origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2000-","dateIssuedKey":"2000","publisherPlace":"London"}],"part":{"text":"23(2022), Artikel-ID 302, Seite 1-13","pages":"1-13","extent":"13","volume":"23","year":"2022"},"language":["eng"],"note":["Gesehen am 26.09.22"],"pubHistory":["1.2000 -"],"disp":"Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT) study protocol for a prospective, multicentre, controlled, randomized, double-blind trialTrials","type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Current controlled trials in cardiovascular medicine"}]}]} | ||
| SRT | |a WEHMEYERMASTOPOFPROT1220 | ||